Journal of Assisted Reproduction and Genetics

, Volume 29, Issue 2, pp 127–129 | Cite as

Severe ovarian hyperstimulation syndrome after letrozole-gonadotropin stimulation: a case report

  • Jayeon Kim
  • Anne Z. Steiner
  • Marc Fritz
  • Jennifer E. Mersereau


Letrozole Polycystic Ovary Syndrome Cabergoline Fertility Preservation Ovarian Hyperstimulation Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update. 2002;8(6):559–77.PubMedCrossRefGoogle Scholar
  2. 2.
    Vlahos NF, Gregoriou O. Prevention and management of ovarian hyperstimulation syndrome. Ann N Y Acad Sci. 2006;1092:247–64.PubMedCrossRefGoogle Scholar
  3. 3.
    Asch RH, Li HP, Balmaceda JP, Weckstein LN, Stone SC. Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups. Hum Reprod. 1991;6(10):1395–9.PubMedGoogle Scholar
  4. 4.
    Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab. 2006;91(10):3885–90.PubMedCrossRefGoogle Scholar
  5. 5.
    Practice Committee of American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril. 2008;90(5 Suppl):S188–93.Google Scholar
  6. 6.
    Shetty G, Krishnamurthy H, Krishnamurthy HN, Bhatnagar S, Moudgal RN. Effect of estrogen deprivation on the reproductive physiology of male and female primates. J Steroid Biochem Mol Biol. 1997;61(3–6):157–66.PubMedCrossRefGoogle Scholar
  7. 7.
    Badawy A, Elnashar A, Totongy M. Clomiphene citrate or aromatase inhibitors combined with gonadotropins for superovulation in women undergoing intrauterine insemination: a prospective randomised trial. J Obstet Gynaecol;30(6):617–21.Google Scholar
  8. 8.
    Oktay K, Turkcuoglu I, Rodriguez-Wallberg KA. GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation. Reprod Biomed Online;20(6):783–8.Google Scholar
  9. 9.
    Aboulghar MA, Mansour RT. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum Reprod Update. 2003;9(3):275–89.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Jayeon Kim
    • 1
  • Anne Z. Steiner
    • 1
  • Marc Fritz
    • 1
  • Jennifer E. Mersereau
    • 1
  1. 1.Department of Obstetrics and Gynecology, Division of REIUniversity of North CarolinaChapel HillUSA

Personalised recommendations